Takeda Ventures
Profile, fund size and portfolio
Takeda Ventures is the corporate venture arm of Takeda Pharmaceutical Company Limited (pharmaceuticals). It was founded in 2001 and is based in Cambridge, United States. It invests from Seed to Series A in oncology, rare Genetics & Hematology, neuroscience.
Every figure links to its source
Snapshot
Data behind this graphic
| Item | Value |
|---|---|
| Stage range | Seed to Series A |
| Sectors | Oncology, Rare Genetics & Hematology, Neuroscience, Gastrointestinal and Inflammation, Digital health |
| Geography | Companies around the world, Takeda Digital Ventures: global, with a concentration in North America and Europe |
| Offices | Cambridge, Massachusetts, United States |
Sources: S1 Takeda Center for External Innovation: Takeda Ventures, Inc.
Data behind this graphic
The firm has not published a portfolio breakdown.
Sources: .
Data behind this graphic
| Measure | Value | Unit | Kind | Source |
|---|---|---|---|---|
| Headline size | Not disclosed by the firm. | |||
| Companies backed | 60+ | companies | Reported in the press | S5 |
| Companies on the firm's portfolio page | 10 | companies | Counted from the firm's own list | S2 |
Sources: S5 Integra Therapeutics appoints Miles Gerson as Independent Chairman; S2 Takeda Digital Ventures (separate Takeda CVC group, portfolio list).
Where it invests and who leads it
Geography
- Headquarters
- Cambridge, United States
- Offices
- Cambridge, Massachusetts, United States
Investment regionsS1
- Companies around the world
- Takeda Digital Ventures: global, with a concentration in North America and Europe
LeadersS4S5S8
- Michael MartinFormer President, CEO and Global Head (2017 to January 2024)Find on LinkedInFirm page
- Miles GersonFormer Global Head and President (January 2024 to mid 2025)Find on LinkedInFirm page
- Sacha MannSenior Partner (appointed 2021; current status not confirmed)Find on LinkedInFirm page
Profile in progress. This firm does not yet meet our publishing minimum: sources, leaders. It is not indexed by search engines until it does.
Key facts
| Fact | Value | Status | Source |
|---|---|---|---|
| Parent company | Takeda Pharmaceutical Company Limited (TSE: 4502; NYSE: TAK) | Single source | S3 |
| Parent industry | Pharmaceuticals | Single source | S1 |
| Founded | 2001 | Single source | S1 |
| Headquarters | Cambridge, United States | Single source | S3 |
| Status | Active | Single source | S3 |
| Capital source | Parent company only | Single source | S1 |
| Companies backed | 60+ | Single source | S5 |
| Stages | Seed, Series A | Single source | S1 |
For founders
| Item | What the firm says | Source |
|---|---|---|
| Stages | Seed, Series A | S1 |
| Beyond capital | Access to the resources of a multinational pharmaceutical company; partners with academic innovators, entrepreneurs and venture investors | S1 |
| TVI@takeda.com | S1 |
Notable outcomes
IPOs and acquisitions of portfolio companies. Price shown only where published.
Portfolio
The firm's portfolio page lists 10 companies: 2 exited.S2
The firm also states 60+ companies backed. The page list and the stated total measure different things.S5
Every company on the Takeda Ventures list
10 companies, as listed on the firm's own website: 8 listed, 2 exited.S2 Read the firm's list.
Listed 8
- Amwell
- aptihealth
- Boulder Care
- Ishi Health
- Maia Oncology
- Oshi Health
- Rheumission
- Tele911
Exited 2
- Aspen RxHealth
- Gaido Health
Recent rounds
| Date | Company | Round | Amount | Led by the firm | Source |
|---|---|---|---|---|---|
| 2025-01-27 | Harness Therapeutics | Series A (per databases; amount not disclosed) | Not stated | S6 |
History
Official pages
Read the firm's own pages for current information.
- Website www.takeda.com/science/research-and-development/partnerships/cei/
- Portfolio www.takeda.com/science/research-and-development/partnerships/tdv/
- LinkedIn company page www.linkedin.com/company/takeda-ventures-inc-
Sources
- S1Takeda Center for External Innovation: Takeda Ventures, Inc.Firm
- S2Takeda Digital Ventures (separate Takeda CVC group, portfolio list)Firm
- S3Takeda Ventures, Inc. LinkedIn company pageFirm
- S4Global Venturing: Takeda Ventures loses global head (Michael Martin)Press
- S5Integra Therapeutics appoints Miles Gerson as Independent ChairmanPortfolio company
- S6Harness Therapeutics funding from Ono Venture Investment (existing investors incl. Takeda Ventures)Portfolio company
- S7Miles Gerson LinkedIn (search result)Third-party report
- S8Global Venturing: Mann takes on Takeda Ventures role (Jul 2021)Press
- S9Global Venturing: Gerson advances at Takeda Ventures (Apr 2023)Press
Disclaimer and corrections
Not affiliated. This page is not affiliated with, endorsed by or sponsored by Takeda Ventures or any company named on it. Names and trademarks belong to their owners. Informational only. This is a public-source reference. It is not investment, legal or tax advice and not an offer or solicitation. Sources. Each figure names its source. Figures may have changed. Please read the firm's official pages, linked above. Corrections and takedown. To report an error or ask for a change or removal, use the correction form or email Richard@CorporateVentureCapital.com.
Spotted a mistake? Report a correction.